-
761
Medicinal products used for the treatment and prophylaxis of COVID-19
Published 2020-06-01Subjects: Get full text
Article -
762
Social Media, Conspiracy Beliefs, and COVID-19 Vaccines: A Survey Study of Emerging and Middle-Aged Adults in the United States
Published 2025-01-01Subjects: Get full text
Article -
763
Risk of hospitalization of diagnosed COVID-19 cases during the pandemic: A time-series analysis to unveil short- and long-run dynamics
Published 2024-03-01Subjects: Get full text
Article -
764
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
Published 2025-02-01Subjects: Get full text
Article -
765
-
766
What made people (more) positive toward the COVID-19 vaccine? Exploring positive and negative deviance perspectives
Published 2025-02-01Subjects: “…Vaccination…”
Get full text
Article -
767
-
768
The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
Published 2025-01-01“…Vaccines…”
Get full text
Article -
769
mRNA-LNP vaccines combined with tPA signal sequence elicit strong protective immunity against Klebsiella pneumoniae
Published 2025-01-01Subjects: Get full text
Article -
770
Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China
Published 2025-12-01Subjects: “…Enterovirus 71 vaccine…”
Get full text
Article -
771
Comparison of Long-Term Antibody Titers in Calves Treated with Different Conjunctival and Subcutaneous <i>Brucella abortus</i> S19 Vaccines
Published 2025-01-01Subjects: Get full text
Article -
772
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice
Published 2025-01-01“…npj Vaccines…”
Get full text
Article -
773
Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity
Published 2025-02-01Subjects: Get full text
Article -
774
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines
Published 2015-01-01“…Nowadays different licensed meningococcal vaccines are available and used: conjugate meningococcal C vaccines, tetravalent conjugate vaccines, an affordable conjugate vaccine against the N. menigitidis serogroup A, and universal vaccines based on multiple antigens each one with a different and peculiar function against meningococcal group B strains.…”
Get full text
Article -
775
Haemophilus parasuis Subunit Vaccines Based on Native Proteins with Affinity to Porcine Transferrin Prevent the Expression of Proinflammatory Chemokines and Cytokines in Pigs
Published 2013-01-01“…The expression of chemokines (CCL-2 and CXCL-8) and cytokines (IL-1α, IL-1β, IL-6, TNF-α, and IL-10) was evaluated by RT-qPCR in colostrum-deprived pigs vaccinated and challenged with Haemophilus parasuis serovar 5. …”
Get full text
Article -
776
ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIV
Published 2025-01-01Subjects: Get full text
Article -
777
Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
Published 2024-01-01“…WHO recommends HBV-negative babies in high-prevalence (8%) countries receive anti-HBV vaccination. Ghana initiated mass immunization in 2002, but concerns remain about vaccine effectiveness and long-term protection. …”
Get full text
Article -
778
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
Published 2022-01-01“…Samples were collected from 42 SARS-CoV-2 infected patients during the first pandemic wave, 50 subjects who received 2 doses of mRNA vaccine before the Omicron wave, 44 subjects who received 3 doses of mRNA vaccine, and 35 subjects who received heterologous vaccination (2 doses of adenovirus-based vaccine plus mRNA vaccine) during the Omicron wave. …”
Get full text
Article -
779
AVAILABILITY AND ACCEPTABILITY OF COVID-19 VACCINE AMONG NON-TEACHING STAFF OF LAGOS STATE UNIVERSITY, OJO, LAGOS
Published 2024-07-01Subjects: Get full text
Article -
780
N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
Published 2013-01-01“…The lack of in vitro cultures for P. vivax represents a major delay in developing a functional malaria vaccine. One of the major candidates to antimalarial vaccine is the merozoite surface protein-1 (MSP1), which is expressed abundantly on the merozoite surface and capable of activating the host protective immunity. …”
Get full text
Article